Story thread · 2 reports / 2 sources
Veru targets Q1 2027 PLATEAU interim analysis after enrolling 239 patients
seekingalpha.com · 1d
First report: Veru completes enrollment of obesity drug trial with 239 patients — investing.com, 1d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.